Citation 76034

PETTIT,GR: GAO,F: BLUMBERG,PM: HERALD,CL: COLL,JC: LEWIN,NE: SCHMIDT,JM: CHAPUIS,JC:. (1996). ANTINEOPLASTIC AGENTS. 340. ISOLATION AND STRUCTURAL ELUCIDATION OF BRYOSTATINS 16-18.. 59(3)

Citation Details

TitleANTINEOPLASTIC AGENTS. 340. ISOLATION AND STRUCTURAL ELUCIDATION OF BRYOSTATINS 16-18.
AuthorsPETTIT,GR: GAO,F: BLUMBERG,PM: HERALD,CL: COLL,JC: LEWIN,NE: SCHMIDT,JM: CHAPUIS,JC:
Year1996
Volume59
Issue3

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Bugula neritina (BUGULIDAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
BRYOSTATIN 16
None
2
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 16
ACTIVE
3
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 16
ACTIVE
4
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 16
ACTIVE
5
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 16
ACTIVE
6
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 16
ACTIVE
7
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 16
ACTIVE
8
CYTOTOXIC ACTIVITY
PMR SPECTRUM REPORTEDCMR SPECTRUM REPORTED
BRYOSTATIN 16
ACTIVE
9Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
BRYOSTATIN 17
None
10
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 17
ACTIVE
11
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 17
ACTIVE
12
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 17
ACTIVE
13
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 17
ACTIVE
14
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 17
ACTIVE
15
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 17
ACTIVE
16
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 17
ACTIVE
17Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
BRYOSTATIN 18
None
18
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 18
ACTIVE
19
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 18
ACTIVE
20
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 18
ACTIVE
21
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 18
ACTIVE
22
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 18
ACTIVE
23
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 18
ACTIVE
24
CYTOTOXIC ACTIVITY
PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE
BRYOSTATIN 18
ACTIVE
25Not specified
ISOLATION AND IDENTIFICATION OF
BRYOSTATIN 4BRYOSTATIN 5BRYOSTATIN 6BRYOSTATIN 7BRYOSTATIN 10BRYOSTATIN 14BRYOSTATIN 8
None
Show SPARQL Queries (1)